One hundred sixty people who suffer from painful diabetic neuropathy have volunteered to participate in a study. Eighty are selected at random and are given the drug gabapentin, which (although originally intended to prevent epileptic seizures) has properties that may make it useful to alleviate neuropathy. The remaining participants are given a placebo. A neurologist evaluates the symptoms of all volunteers after two months to determine if there has been substantial improvement in the severity of the symptoms. This study would be double-blind if: a. neither drug had any identifying marks on it. b. neither the volunteers nor the neurologist were allowed to see each other during the session in which the neurologist evaluated the severity of the symptoms. c. neither the volunteers nor the neurologist knew which subjects had received the drug and which had received the placebo. d. All of the answer options are correct.
Added by Stephen R.
Step 1
A double-blind experiment is one in which neither the researchers nor the subjects know which treatment each subject received. Show more…
Show all steps
Close
Your feedback will help us improve your experience
Ana Carolina Da Cruz and 92 other Intro Stats / AP Statistics educators are ready to help you.
Ask a new question
Labs
Want to see this concept in action?
Explore this concept interactively to see how it behaves as you change inputs.
Key Concepts
Recommended Videos
Sheryl E.
Jon S.
Juvenile Diabetes Treatment Juvenile diabetes (also known as Type 1 diabetes) is usually diagnosed in children and has a genetic component. A recent study enrolled 76 children at high risk for the disease. Half the participants were randomly assigned to a two-week intravenous course of the new drug teplizumab while the other half served as the control group. The study ended as soon as 42 people developed the disease, and the results are shown in the table below. Diabetes No diabetes Total Teplizumab 16 22 38 Control 26 12 38 Total 42 34 76 (a) What proportion of those in the control group developed diabetes? (b) What proportion of those in the teplizumab group developed diabetes? (c) Find the difference in proportions using your answers to parts (a) and (b). (d) Is this an experiment or an observational study? (e) If this difference in proportions appears to be strong, can we conclude that the drug is responsible for stopping and/or delaying the onset of the disease? Yes/No
Kanak I.
Recommended Textbooks
Elementary Statistics a Step by Step Approach
The Practice of Statistics for AP
Introductory Statistics
Transcript
Watch the video solution with this free unlock.
EMAIL
PASSWORD